Research on new, rapid screening test identifies potential therapies against drug-resistant bacteria
Testing of investigational inactivated Zika vaccine in humans begins
Screening method provides a potential new approach to repurpose known drugs and compounds.
Seven substances added to 14th Report on Carcinogens
First of five planned clinical trials to test ZPIV vaccine.
This National Diabetes Month, connect with your community for better health
Five viruses, a chemical, and a metallic element listed in new HHS report.
New method for performing aortic valve replacement proves successful in high-risk patients
NIH statement from Dr. Griffin P. Rodgers, Director, National Institute of Diabetes and Digestive and Kidney Diseases.
Dr. Michael E. Charness to deliver 21st Annual Mark Keller Honorary Lecture at the National Institutes of Health
Findings may increase less invasive treatment options for patients with lethal heart condition.
Scientists propose neuroscience framework for diagnosing addictions
Dr. Charness’ work has greatly advanced our understanding of how alcohol affects the development of the nervous system.
NIH researchers unveil new wound-healing role for protein-folding gene in mice
Tool could lead to more effective individualized treatments for addictions.
Long-term oxygen treatment does not benefit some COPD patients
Gene found to be critical in tissue regeneration and would healing.
Ebola-affected countries receive NIH support to strengthen research capacity
Study addresses long-standing question for those with moderately low blood oxygen levels.
Training programs for scientists and researchers to focus on known and emerging viral diseases.